Harvard Business

MAY 26, 2016

Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. If so, then high profits portend diminished productivity growth. Smaller regulatory changes are also associated with a subsequent rise in firm market values and profits.

Pharmaceuticals 128

Pharmaceuticals Chemicals Industry Study 128

Women in Consulting

AUGUST 21, 2014

In my previous post, I outlined some ways service businesses could market themselves online. How to’s” are often good, as are stories about trends, personalities and any unusual aspect of your product or service. I hope by now you see that, although success is not automatic, there are many ways to market a service. Conclusion.

Marketing 76

Marketing Media Pharmaceuticals Report 76

Harvard Business

OCTOBER 14, 2016

Much of marketing is premised on companies delivering messages to customers to influence their purchases and consumption. Indeed, the largest advertisers in the world are companies such as Procter & Gamble, Nestlé, and Unilever, which sell branded low-involvement products that are routinely purchased and consumed at a regular pace.

Marketing 70

Marketing Advertising Retail Pharmaceuticals 70

Harvard Business

FEBRUARY 26, 2018

Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. “To be able to do that, they need to entice companies to come to Japan, and they need to entice their own pharmaceutical companies to license in and obtain the best.”

Pharmaceuticals 71

Pharmaceuticals Government Research Development 71

Harvard Business

DECEMBER 23, 2016

When partners in an alliance come into conflict, it can be just what is needed to produce a technically and commercially successful product. ” This idea that disagreement and conflict between groups can be productive is not new. Oysters and alliances have something in common: a little irritation can produce a thing of beauty.

Productivity 70

Productivity Survey Resources Training 70

Harvard Business

OCTOBER 13, 2016

Most corporate strategists focus on finding ways to win in the market — that is, they look for sources of competitive advantage based on the customers they serve, the products they sell, the suppliers they use, and so on. Laura Schneider for HBR. But they tend to overlook their nonmarket strategy.

Marketing 70

Marketing Intellectual Property Pharmaceuticals Government 70

Harvard Business

AUGUST 3, 2016

That can benefit consumers through lower prices, more innovation, and better products. On the other hand, M&As can also strengthen the market power of the combined entity, reducing competition in a way that harms consumers. It’s far easier to predict short-run changes in prices and quantities in the current market.

Research 70

Research Pharmaceuticals Company Development 70

Harvard Business

NOVEMBER 24, 2016

This is particularly true for the marketing department, which is changing at such a break-neck pace that marketing success now depends heavily on support from HR to identify and train new skillsets. On the flip side, success in HR could use a major assist from marketing, or at least HR professionals who think like marketers.

Marketing 70

Marketing Recruitment Recruiting Talent 70

Management Consulted

MARCH 18, 2015

In 1954 , Bill Frohlich, and David Dubow, teamed up to form IMS, a market research company aimed at enabling organizations make informed, strategic decisions about the marketplace. By 1969 , they had proven themselves and were held as the gold standard in pharmaceutical market research in Europe and Asia. Practice Areas .

Groups 100

Groups Interviews Culture Consulting 100

Management Consulted

NOVEMBER 6, 2016

Today’s emphasis is on ZS Associates (pronounced Zee S in the USA) – a premier boutique firm focused on sales force and marketing optimization. Founded in 1983 by Kellogg School of Management marketing professors Andris A. Where did ZS Associates begin, and what are they known for?

Case Interview 100

Case Interview Interviews Sales Pharmaceuticals 100

Harvard Business

MARCH 27, 2018

The velocity in acquiring and exploiting this personal data can help these companies obtain significant market power. He noted his agency’s “particular concerns in digital markets.” Unlike some pharmaceuticals, data-opolies do not charge consumers exorbitant prices. Lower-quality products with less privacy.

Data 130

Data Company Advertising Engineering 130

Harvard Business

APRIL 3, 2017

I had to tell my Australian friend that locking and loading on Where to Play choices, rather than setting the table for a great discussion of How to Win, actually makes it virtually impossible to have a productive consideration of How to Win. But being huge and important didn’t make that choice inherently meritorious.

Retail 134

Retail System Pharmaceuticals Strategy& 134

Harvard Business

FEBRUARY 6, 2018

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families. .”

Retail 129

Retail Operations Data Insurance 129

Harvard Business

OCTOBER 25, 2018

Traditionally, organizations have used data analytics as a tool of retrospection, as a means of answering questions like, “Did this marketing campaign reach our desired audience?” Increase the number of products that ship from a certain warehouse? ” or “Who were our highest-value customers over the last year?”

Data 131

Data How To Pharmaceuticals Survey 131

Harvard Business

NOVEMBER 3, 2017

The successful but challenging experience of a large pharmaceutical company illustrates the tension between top-down and decentralized change efforts. Take the example of a global industrial products company that was in the early stages of implementing a growth strategy. The Gap Between Strategy and Execution.

Strategy& 137

Strategy& Strategy Strategy Pharmaceuticals 137

Harvard Business

OCTOBER 25, 2018

We focus on economic profit rather than revenue size, market share, or productivity growth because these other metrics risk including firms that are simply large and may not create economic value. Productivity can help; but it is not enough to achieve superstardom.

Industry 132

Industry Company Metrics Real Estate 132

Harvard Business

SEPTEMBER 4, 2017

Confronted with intense levels of stress amidst turbulent change or the headwinds of a harsh market, leaders’ fuses get short. During an onslaught of major change, sources of irritation can often be circumstances outside anyone’s control, like changing regulatory requirements or a market slow down.

Pharmaceuticals 134

Pharmaceuticals Culture Study Management 134

Harvard Business

OCTOBER 26, 2017

A year later, Lauren was working as a temp to make ends meet when she applied to what was essentially a marketing assistant job. “I told the hiring manager that I had a very firm grasp of those products,” she says. “I also wanted to acquire new skills, so I [could apply them to] future marketing campaigns and jobs.”

Case Interview 134

Case Interview How To Interviews Case Study 134

Harvard Business

MAY 25, 2017

The pipeline for new drugs is bursting, and new devices and tools in the rapidly emerging digital health space will come to market more quickly. Investors are already keenly focused on this area, with many startups competing for a slice of the market. A third growth area is in EHRs and digital health applications.

Trends 107

Trends Healthcare Data Tools 107

Harvard Business

NOVEMBER 28, 2017

One of your executives comes to you with a proposal: she wants to lower the quality of service at the restaurants, reduce product safety standards, use deceptive marketing practices, lower employee pay, and adopt worse environmental practices. Imagine you’re the CEO of a casual dining chain. But these effects were limited.

Company 74

Company Productivity Efficiency Study 74

Harvard Business

MAY 10, 2018

But China also has a huge domestic market for fake goods: many consumers who buy counterfeits do so deliberately, because they want to pay a lower price for goods that look expensive. Do not wait until you actually enter the Chinese market. A store that guarantees the authenticity of all products it sells is a big relief for them.

Intellectual Property 71

Intellectual Property Pharmaceuticals Government Accenture 71

Management Consulted

OCTOBER 3, 2012

For instance, we examined predatory pricing in the airline industry and illegal product tying by Apple, Microsoft, and AT&T. market for latex condoms. Recently, Mayer Laboratories sued Church and Dwight, Trojan’s parent company, for illegally monopolizing the market. My group chose to examine the U.S.

Consulting 204

Consulting Case Interview Interviews Engineering 204

BCG

AUGUST 23, 2016

To capture the immense opportunities in emerging markets, pharmaceutical companies require highly targeted strategies. And what works in developed markets won’t necessarily work in emerging economies. The payoff for getting a targeted emerging-market strategy right is significant.

Pharmaceuticals 40

Pharmaceuticals Case Study Case Studies Sales 40

Harvard Business

OCTOBER 26, 2017

Nowadays, when a multitude of businesses are confronted with the leap from “dumb” products to creating smart, connected ones , and cities and regions are trying to make the leap from manufacturing to services, relying too heavily on past successes will only lock those clusters in the past. Moreover, a cluster can never be static.

Education 71

Education Pharmaceuticals Industry Exercises 71

Consultant Ninja

JULY 31, 2009

I do not necessarily agree with nationalized healthcare, but would assert that productive discussion of the issue must be based on specific arguments about what is effective, fair, and affordable for the nation. What cost control levers are available to reign in pharmaceutical / prescription drug costs? Productivity. (6).

Consulting 100

Consulting Oliver Wyman Management Insurance 100

Harvard Business

AUGUST 24, 2017

We focused on nine common types of corporate litigation: antitrust, employment civil rights, contract, environmental, intellectual property, labor, personal injury, product liability, and securities. We predicted that the market would reward firms with lawyer CEOs, who would be better able to navigate the new regulatory environment.

Pharmaceuticals 72

Pharmaceuticals Intellectual Property Training Training 72

MishTalk

AUGUST 18, 2014

Contrast that with the three lowest usages of pharmaceuticals, food, and plastics. It''s obvious robots increase productivity. Sitka Pacific is an asset management firm whose goal is strong performance and low volatility, regardless of market direction. How long will that be? I side with the editor. I side with the editor.

Automotive 78

Automotive Pharmaceuticals Sales Policies 78

Harvard Business

NOVEMBER 12, 2018

” As this first wave of genetic treatments hits the market, industry leaders face a stark choice. Put another way, product classes with fundamentally new performance profiles can’t be dropped into an existing business model and expected to work. Creating better outcomes at reduced cost. New business models.

Insurance 127

Insurance Insurance Healthcare System 127

Management Consulted

OCTOBER 18, 2013

During this same time, IBM and Coopers & Lybrand formed Meritus Consulting Services to provide strategic advice to businesses in the consumer packaged goods, pharmaceutical, aerospace, and automotive industries. Marketing Sales & Service. Consumer Products. Financial Markets. Fast forward to today. Finance Risk.

IBM GBS 203

IBM GBS Interviews Consulting Case Interview 203

Harvard Business

JUNE 16, 2016

In July 2015, Novartis launched its new heart failure drug, Entresto, which Forbes in 2014 predicted would be a blockbuster — with expected sales of $10 billion annually — as the potential market in the US exceeds 5 million people with a heart failure condition. The failure stemmed from resistance in the U.S.

Pharmaceuticals 70

Pharmaceuticals Sales Insurance Insurance 70

Harvard Business

SEPTEMBER 14, 2017

A less aggressive mix (say 75:25) is typical in industries such as pharmaceuticals that want salespeople to focus on customer education, and for technical sales jobs that have a large problem-solving component. Products such as chronic care medications have high carryover. Franchise sales have nothing to do with salespeople.

Sales 71

Sales Pharmaceuticals Industry Company 71

Harvard Business

NOVEMBER 2, 2018

Competing for scarce labor in a tight market, they will have trouble continuing to shift medical bills onto employees as they have for several decades. To address these challenges, they will have to band together in purchasing coalitions that give them the local market power to force health systems to reform. Tim Robberts/Getty Images.

Insurance 70

Insurance Insurance Pharmaceuticals System 70

Harvard Business

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. It’s clear why pain in the domestic supplier base matters from a policy perspective.

McKinsey 72

McKinsey Turnaround Pharmaceuticals Benchmarking 72

Harvard Business

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. For example, printing products on demand would significantly reduce the U.S. What happens, for example, if the value of a product’s underlying intellectual property overtakes its production value?

Intellectual Property 70

Intellectual Property Automotive Analysis Pharmaceuticals 70

Harvard Business

MAY 5, 2016

But peruse some of the recent headlines about Iran , and you might wonder whether the market’s potential was overstated. However, despite a weakened economy, political tensions, market uncertainty, and the lingering effects of sanctions, Iran remains an important opportunity for multinationals in emerging markets.

Tourism 70

Tourism Banking Hotels Financial 70

Harvard Business

SEPTEMBER 11, 2014

There’s a similar assumption underlying much of the discussion around how to measure the return on marketing investment, where it seems to be tacitly accepted that attitudinal insights are insufficient at senior decision-making levels, and behavioral insights represent today’s benchmarks.

Survey 71

Survey Pharmaceuticals Benchmarking ROI 71

Harvard Business

DECEMBER 14, 2017

Is free-market magic finally bringing Amazon-style convenience, quality, and efficiency to health care? The hope is that this will reduce patients’ use of more expensive emergency, hospital, and specialty services, thereby reducing Aetna’s bills and making its product more competitive. Could this be it?

System 71

System Insurance Insurance Pharmaceuticals 71